SOLIGENIX, INC. (SNGX) Form 8-K Material Events
SOLIGENIX, INC. (SNGX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SNGX
CIK: 812796
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Cherry Bekaert LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerChristopher Rux
Audit LocationTampa, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-13 | 2026-10-12 | 4 Filing | 0001433982-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-12 | 4 Filing | 0001413631-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-12 | 4 Filing | 0001781026-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-12 | 4 Filing | 0001331860-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-12 | 4 Filing | 0001627575-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-12 | 4 Filing | 0001787282-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-12 | 4 Filing | 0001068029-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-09-21 | 2026-09-17 | 8-K | 0001104659-26-109329 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-17 | 4 Filing | 0001433982-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-17 | 4 Filing | 0001413631-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-17 | 4 Filing | 0001781026-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-17 | 4 Filing | 0001331860-26-000003 | View SEC Doc Filr Page |
| 424B3 | 2026-08-07 | — | 424B3 | 0001104659-26-092711 | View SEC Doc Filr Page |
| 424B3 | 2026-08-07 | — | 424B3 | 0001104659-26-092707 | View SEC Doc Filr Page |
| 424B3 | 2026-08-07 | — | 424B3 | 0001104659-26-092701 | View SEC Doc Filr Page |
| 424B3 | 2026-08-07 | — | 424B3 | 0001104659-26-092698 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001104659-26-092681 | View SEC Doc Filr Page |
| ARS | 2026-08-03 | 2025-12-31 | ARS | 0001104659-26-089799 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-03 | — | DEFA14A | 0001104659-26-089792 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-03 | 2026-09-17 | FORM DEF 14A | 0001104659-26-089789 | View SEC Doc Filr Page |
| PRER14A | 2026-07-23 | — | FORM- PRER14A | 0001104659-26-086341 | View SEC Doc Filr Page |
| PRE 14A | 2026-07-21 | 2026-09-17 | PRE 14A | 0001104659-26-085423 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-26 | 8-K | 0001104659-26-078251 | View SEC Doc Filr Page |
| 424B5 | 2026-06-26 | — | 424B5 | 0001104659-26-078241 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-25 | — | SCHEDULE 13G Filing | 0002103370-26-000002 | View SEC Doc Filr Page |